UC HEALTH LINE: Arm Therapy 'Rewires' Brain After Stroke
CINCINNATIA therapy known to improve arm function in stroke patients actually works by forcing the brain to rewire itself, say UC researchers.
A study led by Stephen Page, PhD, and published in the August 2006 issue of Archives of Physical Medicine and Rehabilitation, reports that when stroke patients participate in modified constraint-induced movement therapy, or mCIMT, areas of their brain normally used for other functions are recruited to help move the affected arm.
Patients in the study were offered 10 weeks of mCIMT, in which restraint of the unaffected arm forced them to use their affected arm for everyday tasks.
Study participants were given 30-minute therapy sessions three times a week. They were asked to follow up at home, still using only their affected arm for five hours each day, five days a week.
Previous studies have shown that mCIMT can improve arm function in patients, but we werent quite sure how it was working, says Page, assistant professor and director of research in the department of physical medicine and rehabilitation. The cool thing about this study is that we now know the mechanism.
That mechanism, referred to by the researchers as cortical reorganization, was confirmed through functional magnetic resonance imaging (fMRI) scans of the participants at the beginning and end of the study.
In patients who benefited from constraint therapy, says Page, fMRI scans clearly show activity in brain areas that werent active at the start of the study
To our knowledge, says Page, this is the first study showing this kind of rewiring. We think its particularly important to stroke patients, because this particular outpatient therapy is often covered by insurance providers, so its quite accessible.
Coauthorsall from UCinclude Brett Kissela, MD, Jing-Huei Lee, PhD, Peter Levine, Stephen Strakowski, MD, and Jerzy Szaflarski, MD.
Tags
Related Stories
Antiretroviral abacavir linked with cardiovascular events in...
![MedPage Today logo](/content/dam/refresh/uc-news/news-icons/dark/medpage-today.png)
July 29, 2024
MedPage Today highlighted research presented by the University of Cincinnati's Carl Fichtenbaum at the International AIDS Conference that found people with HIV who took the antiretroviral drug abacavir (Ziagen) had an increased risk of major adverse cardiovascular events.
UC global health expert hones leadership skills as Fulbright...
July 26, 2024
The University of Cincinnati’s Michelle Burbage worked as a Fulbright Specialist in Tbilisi, Georgia, leading workshops and hands-on activities to build public global health research programs.
Advocates working to get ‘PICS’ named a public health crisis
![Spectrum News logo](/content/dam/refresh/uc-news/news-icons/dark/spectrum-news.png)
July 26, 2024
Spectrum News and WVXU highlighted the research partnership of the University of Cincinnati's Rachael Nolan and community advocate Chazidy Robinson who are working to raise awareness and recognition of post-incarceration syndrome.